1 / 30

Dissolution Measurement System: Current State and Opportunities for Improvement

Dissolution Measurement System: Current State and Opportunities for Improvement. Dr. Lucinda Buhse Director, Division of Pharmaceutical Analysis. Measurement System for Dissolution Rate. Apparatus Current State of Calibration and Validation Sources of Variability

lyneth
Download Presentation

Dissolution Measurement System: Current State and Opportunities for Improvement

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Dissolution Measurement System:Current State and Opportunities for Improvement Dr. Lucinda Buhse Director, Division of Pharmaceutical Analysis

  2. Measurement System for Dissolution Rate • Apparatus • Current State of Calibration and Validation • Sources of Variability • Opportunities for Improvement

  3. USP Dissolution Apparatus • Apparatus 1 - Basket (37º) • Apparatus 2 - Paddle (37º) • Apparatus 3 -Reciprocating Cylinder (37º) • Apparatus 4 –Flow-Through Cell (37º) • Apparatus 5 – Paddle over Disk (32º), Transdermal Delivery System, use paddle and vessel from Apparatus 2 with a stainless steel  disk assembly to hold the transdermal on the bottom of vessel. • Apparatus 6, Cylinder (32º), Transdermal Delivery System, use Apparatus 1 except replace the basket shaft with a stainless steel cylinder element. • Apparatus 7, Reciprocating Holder, for transdermal delivery systems and also a variety of dosage forms

  4. Apparatus 1 Basket Apparatus 2 Paddle

  5. Apparatus 3 (shown) Glass reciprocating cylinder Apparatus 7 Holders a) Reciprocating disk sample holder b) Transdermal system holder - angled disk (32º) c) Transdermal system holder - cylinder (32º) d) Oral extended-release tablet holder—rod, pointed for gluing e) Oral extended-release tablet holder—spring holder

  6. Apparatus 4: Flow Through Cells

  7. Current State for Dissolution Test Methods Most use: • Apparatus 1 (Basket) or Apparatus 2 (Paddle) • USP Equipment Set-Up and Calibration Criteria • One point acceptance criteria for Immediate Release

  8. Current State for Dissolution Test Methods • Instrument Suitability • Choice of instrument • Mechanical Calibration (affecting hydrodynamics) • Calibrator Tablets (USP, not EP, BP or JP) • Method Development / Validation

  9. Current State: Instrument Suitability USP Mechanical Calibration Parameters include: • Basket/Shaft Wobble (No significant wobble) • Vessel/Shaft Centering (2 mm from centerline) • Height check/Basket or Paddle Depth as measured at basket bottom or Paddle bottom (25 + 2 mm) • No significant vibration • Rotational speed (+ 4%) • Vessel Temperature (37.0+ 0.5 C) • Basket Wobble (bottom rim) (+ 1mm)

  10. Calibrator Tablets 1970’s : USP Calibrator Tablets Introduced • Disintegrating – 50 mg Prednisone (Upjohn) • Non Disintegrating – 300 mg Salicylic Acid (Hoffman LaRoche) 1997 : 50 mg Prednisone replaced with 10 mg Prednisone manufactured at University of Maryland 2004 : USP begins search for replacement for 10 mg Prednisone tablet USP: Both Calibrators on a given apparatus (i.e. 4 calibration tests if instrument is used for paddle and basket methods) JP, BP and EP: No calibrator tablets

  11. Current State: Instrument Suitability Calibrators • Every 6 months • 10 mg Prednisone Tablet (Lot O0C056) • Basket: 53 – 77% (now 51-81%) (DPA 72.6 +/- 5.4, n=36) • Paddle: 27 – 48% (now 26-47%) (DPA 31.7 +/- 2.0, n=24) • Salicylic Acid Tablet (Lot O) • Basket: 23 – 29% • Paddle: 17 – 26% • Action with Out of Specification value • Gets in the way of continuous improvement

  12. Current State: Method Development / Validation Development –Discriminatory? Repeatable? • Instrument – which one to use? • Media • Degassing • Sinkers Validation: • Determinative Step – Main Focus • Linearity and Recovery • Filtering • Stability of solutions • Interferences Even if we don’t understand development, we need to understand variability of our system (product, measurement, random)

  13. Managing Variability • Total variability σ2Total • Assuming independent variable (if not independent for example interaction between measurement and product a covariance term needs to be included) • σ2Total = σ2Product + σ2Measurement • σ2Measurement = σ2Repeatability + σ2Reprodicibility • Common Cause Vs. Special Cause variability • Process capability: Customer Needs Process Ability

  14. Current State: Variability • Instrument Suitability • Apparatus Variability • Operator Set-up • Calibrator Assignment Variability • Manufacturing of Calibrator Tablet • Stability • Instrument Set-up • Degassing • Product Specific • Media including degassing • Manufacturing • Dissolution equipment parameters (clips, sensitivity to set-up) • Sinkers • Determinative Step

  15. Variability: Instrument Suitability Set-up Parameters: USP DPA

  16. A B Variability: Media and Degassing Total Dissolved Gas and Oxygen Meter Used for determining water quality in agriculture, fisheries and industry

  17. Variability: Media and Degassing Total Gas Pressure and Oxygen Gas Pressure in Water Degassing by Various Methods

  18. Product 1: paddle, 50 rpm, DI Water Product 2: basket, 100 rpm, pH 1.2 Product 3: paddle, 50 rpm, pH 7.4 buffer Variability: Media and Degassing

  19. Variability: Media or Manufacturing? pH 7.2 pH 6.8

  20. What are the sources of variability at pH 6.8? Variability: Media or Manufacturing? • Product handling during testing? • Tablet to tablet differences? • Instrumentation variation? • Vessel defects? • Inconsistent Centering? • RPM variations • Etc.

  21. Microscope Images of the Coating Variability: Media or Manufacturing?

  22. Variability Sinkers Product 1: paddle, 50rpm, DI water, off-center 10mm Sinkers are sometimes needed to hold product at the bottom of the dissolution vessel.

  23. Variability Sinkers Commercial Sinker 3 Wire Turns 60% - 72% Dissolved at 30 min. 66% ± 4% 89% – 99% Dissolved at 30 min. 95% ± 4%

  24. Opportunities for Improvement • Alternative regulatory approach to dissolution calibration and validation • Understand and control measurement system variability • Understand the product specific sources of variability • Understand relationship between physicochemical properties and dissolution results • Understand the benefits and limitations of different dissolution apparatus – develop scientific criteria • Investigate new approaches to assess product quality and availability • Communication and training of FDA personnel

  25. Alternative approach to dissolution calibration and validation • Stringent Mechanical Calibration to replace the need for a calibrator tablet • ID and Control all sources of variability • Apparatus Type including sinkers • Set-up Parameters • Media including degassing • Understanding of interaction between instrument and product during pharmaceutical development • If necessary, establish an internal calibrator (biobatch or clinical batch) for system suitability and stability • Confirm suitability using Gauge R&R using pivotal clinical trial product or pivotal “bio-batch”

  26. Gauge R&R Design • Chance to characterize variability on an internal reference • Make it representative • Controlled manufacturing process • For design include variables such as • Instrument • Personnel • Media

  27. Understand the benefits and limitations of different dissolution apparatus • Use design and development information to help choose an apparatus • Model dissolution environments and understand hydrodynamics from first principles • Look beyond apparatus 1 and 2 to alternative systems that may be easier to model and test (i.e., flow through?)

  28. Investigate new approaches to assess product quality and availability • New tools to assess product and media variability • Spectroscopy? NIR, RAMAN, Terahertz • PAT including feedback loops • First principles and modeling

  29. Acknowledgements • Terry Moore • Zongming Gao • Lawrence Yu • Ajaz Hussain

  30. 10-mg Prednisone Tablet DPA Distribution USP Limits Paddle Limits: 27 - 48% DPA: 31.7 +/- 2.0 n=24 Basket Limits: 53 - 77% DPA: 72.6 +/- 5.4 n=36 % Dissolved

More Related